Back to 
Los Angeles Capital Management LLC
Los Angeles Capital Management LLC
PACB
Showing 2 of 18 quarters
Position history for Los Angeles Capital Management LLC's holdings in Pacific Biosciences of California, Inc.
No. Los Angeles Capital Management exited its PACB (Pacific Biosciences of California) position in Q1 2026. Its Q4 2025 13F listed 3,590 shares worth $6,965. Los Angeles Capital Management first reported PACB in Q2 2020 and held it in 15 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$6,965
Total Shares Change
-3,590
Quarter-by-Quarter History